• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials.

广告
作者: Xinan,Sheng [1] ; Lin,Wang [2] ; Zhisong,He [3] ; Yanxia,Shi [4] ; Hong,Luo [5] ; Weiqing,Han [6] ; Xin,Yao [7] ; Benkang,Shi [8] ; Jiyan,Liu [9] ; Changlu,Hu [10] ; Ziling,Liu [11] ; Hongqian,Guo [12] ; Guohua,Yu [13] ; Zhigang,Ji [14] ; Jianming,Ying [15] ; Yun,Ling [15] ; Shiying,Yu [16] ; Yi,Hu [17] ; Jianming,Guo [18] ; Jianmin,Fang [19] ; Aiping,Zhou [20] ; Jun,Guo [2]
作者单位: Department of Genitourinary Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China. [1] Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. [2] Department of Urology, Peking University First Hospital, Institute of Urology, National Urological Cancer Center of China, Peking University, Beijing, China. [3] Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. [4] Department of Genitourinary Oncology, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing, China. [5] Department of Urology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine of Central South University, Changsha, China. [6] Department of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China. [7] Department of Urology, Qilu Hospital of Shandong University, Jinan, China. [8] Department of Biotherapy, Cancer Center, and National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China. [9] Department of Medical Oncology, Anhui Provincial Cancer Hospital, Hefei, China. [10] Department of Cancer Centre, First Hospital of Jilin University, Changchun, China. [11] Department of Urology, Nanjing Drum Tower Hospital, Nanjing, China. [12] Department of Medical Oncology, Weifang People's Hospital, Weifang, China. [13] Department of Urology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. [14] Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer /Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. [15] Department of Urology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China. [16] Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China. [17] Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China. [18] RemeGen, Ltd, Yantai, China. [19] School of Life Science and Technology, Tongji University, Shanghai, China. [20]
DOI 10.1200/JCO.22.02912
PMID 37988648
发布时间 2024-05-22
提交
  • 浏览4
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷